The improving life expectancy for CF is known to be one of the biggest success stories in medicine. Life expectancy has increased from 6 months during the early 20th century to 42.7 years from in 2012-2016. As the life expectancy of CF patients has increased, it is important to consider other co-morbidities that these patients may encounter, and the impact this may have on their morbidity and mortality. We present a case of a 33-year-old male admitted to the hospital for a CF exacerbation who had an acute neurological decompensation due to an infarction of his right occipital and posterior temporal lobe.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171483PMC
http://dx.doi.org/10.1016/j.rmcr.2018.09.013DOI Listing

Publication Analysis

Top Keywords

life expectancy
16
devastating cardiovascular
4
cardiovascular event
4
event adult
4
adult cystic
4
cystic fibrosis
4
fibrosis patient
4
patient unforeseen
4
unforeseen outcome
4
outcome increasing
4

Similar Publications

Background: As life expectancy increases, the number of older adults with functional limitations is also increasing. Functional limitations are associated with adverse health outcomes such as reduced independence, diminished quality of life (QoL), and disability. Therefore, identifying which activities of daily living (ADLs) are limiting and understanding the influencing factors are crucial for developing tailored interventions.

View Article and Find Full Text PDF

Modification of gemcitabine with oxaliplatin in China for unresectable gallbladder cancer: a cost-effectiveness analysis.

Front Public Health

December 2024

Department of Pharmacy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Background: The incidence of gall bladder cancer (GBC), one of the most prevalent bile duct malignancies, differs with ethnicity and geographic location. To treat unresected GBC in the Chinese setting, this study aimed to assess the financial effectiveness of a combination of modified gemcitabine and oxaliplatin.

Methods: Data from a randomized controlled study in which individuals with metastatic GBC were treated with oxaliplatin and gemcitabine demonstrated improved survival.

View Article and Find Full Text PDF

The current status of trauma care for older adults in Saudi Arabia.

Front Med (Lausanne)

December 2024

Sheffield Centre for Health and Related Research, University of Sheffield, Sheffield, United Kingdom.

The aging population in Saudi Arabia presents unique challenges to the trauma care system, especially in prehospital settings. This narrative review aims to assess the current status of trauma care for older adults in Saudi Arabia, focusing on the implications of aging, gaps in the trauma system, and the role of emergency medical services. The global rise in life expectancy has increased the incidence of injuries among older adults, leading to a greater burden on healthcare systems.

View Article and Find Full Text PDF

Background: Prostate cancer is now one of the most prevalent cancers in men in Asia. As the average life expectancy of Asian males with prostate cancer increases with the availability of treatment options, the possible risk of cardiac-related adverse effects arising from androgen-receptor-targeted agents (ARTAs) may be increased due to the greater exposure. We aim to perform a meta-analysis on the incidence of cardiac-related adverse events in Asian patients with prostate cancer treated with ARTAs.

View Article and Find Full Text PDF

Introduction Medical advances and improved living standards have increased life expectancy, and the percentage of older adults is growing rapidly. The proportion of older adults visiting the emergency department (ED) is also increasing. Frailty is recognized as a significant risk factor for adverse outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!